GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline...
查看详情Great news! On May 18, Bio-Thera's recombinant humanized anti-VEGF monoclonal antibody injection(BAT1706) was approved f...
On March 15, there was some big news for one of Bio-Thera's major pipeline products. The phase I clinical trial for BAT1...
